[Progress in the field of drug development. 6].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000477:Alkylating Agents / Q000494:pharmacology; D000614:Aminocaproates / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology; D003331:Coronary Vessels / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D050356:Lipid Metabolism; D008659:Metabolic Diseases / Q000188:drug therapy; D008697:Methane / Q000494:pharmacology; D008738:Methyl Ethers / Q000494:pharmacology; D008777:Methyltestosterone / Q000494:pharmacology; D010600:Pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000477:Alkylating Agents; D000614:Aminocaproates; D000889:Anti-Arrhythmia Agents; D000903:Antibiotics, Antineoplastic; D000959:Antihypertensive Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001565:Benzoates; D002301:Cardiac Glycosides; D004232:Diuretics; D008738:Methyl Ethers; D014665:Vasodilator Agents; D005934:Glucagon; D008697:Methane; D008777:Methyltestosterone
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. 6.